Why Can't the Brain Shake Cocaine?

While celebrities and U.S. entanglement in the Colombian drug war keep cocaine in the headlines, a larger tragedy hides in the unseen lives of both addicts and former addicts. In 1999, 1.5 million Americans took cocaine at least once a month, according to the federal government's National Household Survey on Drug Abuse. The problem's vast size is aggravated by two stubborn realities: many addicts just can't quit, and those who do might relapse when stressed or tempted. Both groups suffer because

Written byDouglas Steinberg
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Biologists began investigating the neuronal changes underlying cocaine addiction many years ago. Some studies focused on what was happening on cell membranes; others tackled the less accessible molecular and genetic developments inside neurons. About five years ago, this intracellular approach largely petered out in the face of dauntingly complex biochemical pathways and proteins with unfathomable functions. A few labs persisted, however, and their explorations are starting to hit pay dirt. In March, for example, a team of 12 neuroscientists published a Nature paper detailing, for the first time, how chronic cocaine exposure affects several proteins along a critical signal transduction pathway in neurons.1

The ultimate goal of all this research is to tease out how short-term changes in intracellular proteins lead to the lifelong bodily changes that maintain addiction and cause relapse. One key protein identified in the Nature paper, cyclin-dependent kinase 5 (Cdk5), is "a very good candidate for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies